Glaukos commences trials for its third-generation keratoconus therapy
Glaukos has commenced a Phase 2 clinical program for its third-generation iLink therapy designed to treat keratoconus. The ophthalmic medical ...
Glaukos has commenced a Phase 2 clinical program for its third-generation iLink therapy designed to treat keratoconus. The ophthalmic medical ...
Organisers of KeraClub 2021 have unveiled the speaker line up for this month’s event, which will have a particular focus ...
Corneal collagen cross-linking revolutionised treatment for keratoconus patients when it was introduced in the late 1990s, but it was a ...
The first corneal allogenic intrastromal ring segment (CAIRS) surgery in Australia has been performed at the Queensland Eye Institute ...
A free webinar for optometrists managing keratoconus and dry eye patients will explain how they can access one of the ...
A new study conducted in New Zealand has revealed keratoconus is prevalent in 30% to 38% of people with Down ...
Keratoconus is common. In fact, it’s so prevalent that I see it most days I’m in the clinic. The typically ...
Australia’s Capricornia Contact Lens is set to take its specialty products to the lucrative Chinese market after signing a 10-year ...
KeraClub is a community event organised by the Save Sight Institute (SSI) to link keratoconus (KC) patients with researchers and ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited